- ESCMID survey on the routine diagnosis and treatment of visceral leishmaniasis -

mandatory answer

Question 1

Thank you to enter here your pseudonym

Question 2

Identification
You work in :

Question 3

You are located in :

Comments

Question 4

You are located in :

Comments

Question 5

There is a reference center for leishmaniasis in your country :

Question 6

Your volume of analysis is :

Comments

Question 7

Your volume of analysis is :

Comments

Question 8

Sample used for the diagnosis of VL
Among this sample types, which one are possibly processed in your lab :

Question 9

Among this sample types, which one is recommended in first-line for the diagnosis of VL in your hospital :

Question 10

Diagnostic strategy
Direct examination is :

Question 11

Culture of leishmania is :

Question 12

Serological tests are :

Question 13

Molecular detection is :

Question 14

Identification of Leishmania is performed using :

Comments

Question 15

Diagnostic Tools
Direct examination is performed

Comments

Question 16

Culture is performed using (*supplemented means fetal calf serum +/- antibiotics :

Comments

Question 17

Serology is performed using :

Comments

Question 18

Molecular detection is performed using :

Question 19

Molecular detection is performed using what target : please cite
Targets of the primers available in your lab are :

Comments

Question 20

Targets for the sequencing available in your lab are :

Comments

Question 21

Principles of treatment in your hospital, when adapted :
Drugs available in your hospital for the treatment of VL are :

Comments

Question 22

The first-line treatment in adults is :

Comments

Question 23

The second-line treatment in adults is :

Comments

Question 24

The first-line treatment in children is :

Comments

Question 25

The second-line treatment in children is :

Comments

Question 26

When using liposomal Amphotericin B (AmBisome), please specify the total dose and administration Schedule for :

Comments

Question 27

When using liposomal Amphotericin B (AmBisome), please specify the total dose and administration Schedule for :

Comments

Question 28

When using liposomal Amphotericin B (AmBisome), please specify the total dose and administration Schedule for :

Comments

Question 29

When using liposomal Amphotericin B (AmBisome), please specify the total dose and administration Schedule for :

Comments

Question 30

Follow-up during treatment
Do you have access to in vitro sensitivity testing of Leishmania isolates

Question 31

Do you think that in vitro sensitivity testing of Leishmania would be helpful for the choice of the drug :

Question 32

Do you have access to pharmacological drug monitoring in your hospital :

Question 33

Do you think that pharmacological drug monitoring would be helpful for the choice of the drug :

Question 34

On what sample do you assess the success or the failure of VL treatment :

Comments

Question 35

At what term do you consider that the VL treatment succeeded or failed and on what sample :

Comments

Question 36

Principles of prophylaxis in immunocompromised patients
The first-line treatment for secondary prophylaxis in adults is :

Comments

Question 37

The first-line treatment for secondary prophylaxis in children is :

Comments

Question 38

When using liposomal Amphotericin B (AmBisome), please specify the total dose and administration schedule for secondary prophylaxis :

Question 39

When using another drug, please specify the total dose and administration schedule for secondary prophylaxis :